Silent Cerebral Infarcts in Sickle Cell Disease - DREPANO-Site

Patients with Silent Strokes and No Treatment. Blood 2002 ... Transfusion. Therapy. Absolute. Risk. Reduction. Relative. Risk. Reduction ... Excessive iron stores.
352KB taille 16 téléchargements 226 vues
Silent Cerebral Infarcts in Sickle Cell Disease

Objectives • Definition of silent strokes • Epidemiology • Mimics of silent strokes • Silent Infarct Transfusion Trial

Definition of Silent Strokes •



CSSCD – Increased signal on T2 weighted image on MRI with no history of a focal neurologic deficits SIT Trial – T2 weighted image on MRI with no history of a focal neurologic deficit and a normal neurologic examination by a pediatric neurologist Glauser et al. (J Child Neurol 1995; 10:88-92

Silent Infarct Mimics on MRI • Terminal Zones of Myelination • Virchow Robbins Spaces • Periventricular Leukomalacia

What is the prevalence of silent cerebral infarcts?

Prevalence of Silent Cerebral Infarcts at Institutions who Performed Surveillance MRI Examinations Reference

Number of Silent Cerebral Infarcts

Total Number of Patients

Prevalence

95% Confidence Interval

Pegelow, 2002

58

266

21.8%

16.8-26.8

Bernaudin, 2000

23

155

15%

9.4-20.6

Kirkham, 2000

16

64

25%

14.4-35.6

SIT

137

386

35%

31-40

Morbidity of Silent Cerebral Infarcts • Global IQ and specific cognitive domains scores are lower than children with SCA and normal MRIs •

Pediatrics. 1996; 97: 864-70



Neurology 1998; 50:1678-1682

• The rate of grade failure is twice that of children with normal MRIs and five times higher than sibling control •

Neurology 2001; 56(8):1109-1111.

• Lesion volume influences the magnitude of global IQ loss in silent cerebral infarcts •

J of Child Neurology 2002; 17:891-895

Silent Strokes Are Morbid, But Are They Progressive?

Patients with Silent Strokes and No Treatment Blood 2002; 99:3014-8

n=248 Mean age of first MRI = 8.3 years Mean follow up to second MRI= 5.2 years

Why Choose Blood Transfusion Therapy and How Effective Would You Expect Blood To Be?

Absolute and Relative Risk Reduction of Neurologic Progression in Patients with Sickle Cell Anemia Receiving Blood Transfusion Therapy

Primary Stroke Prevention with an Elevated TCD Measurement

Secondary Prevention of Stroke Two Years After Initial Stroke

Rate of Stroke Without Transfusion Therapy

Rate of Stroke With Transfusion Therapy

Absolute Risk Reduction

Relative Risk Reduction

14.9%

1.6%

13%

89%

50%

8%

42%

84%

Outcome at 36 Months for Subjects With and Without Silent Infarcts

Arch Neurol 2001 Dec;58(12):2017-21

Values

Benefits Reduced Rate of Strokes Pain ACS

Burden Blood transfusion/monthly Viral infection Excessive iron stores Direct and indirect costs

Silent Cerebral Infarct Transfusion Trial: Multi-Center Clinical Trial Funded by NINDS •

Primary Hypothesis: Prophylactic blood transfusion therapy in children with silent cerebral infarcts will result in at least 86% reduction in the proportion of patients with clinically evident strokes or new or progressive silent cerebral infarcts

• • •

24 clinical sites (Canada, UK and France) Statistical and Imaging Core Center 6.5 year study

Genetic Repository • DNA will be collected on 1880 study participants and stored at Johns Hopkins – Linked clinical database with biologic repository – Unique opportunity to study a large, well characterized patients with and without a single outcome (silent strokes) – Opportunities for studying genetic modifiers

Patient’s Origin Frequency United States United Kingdom Africa France Caribbean Unknown N = 351

286 27 15 15 2 3

% 81.48 7.69 8.55 4.25 0.57 0.85

Patient’s Race Frequency

%

Black

337

96.01

Asian

1

0.28

White

2

0.57

Other

11

3.13

N = 351

722 patients 6 through 12 years of age with hemoglobin SS or SB° and no history of stroke were approached to participate in the study 336 children declined to participate in the study

386 accepted screening

137 children had a positive MRI 4 children had a TCD > transfusion threshold

249 children had a negative MRI

133 children had a TCD < transfusion threshold

55 children were randomized and agreed to allocation

Thank You